
None of 80 outpatients who received fluvoxamine in a clinical trial became seriously ill after 15 days.
None of 80 outpatients who received fluvoxamine in a clinical trial became seriously ill after 15 days.
Our Dr. Taison Bell has been named one of Business Insider’s “30 Leaders Under 40 Changing Healthcare.”
Our Cancer Center is teaming up with 16 other cancer centers around the country to address the effects of the COVID-19 pandemic on cancer detection, care and prevention.
Our Medical Alumni Association has talked with Dr. K. Craig Kent, UVA’s executive vice president for health affairs, about how COVID-19 has affected UVA and UVA Health.
Our Bill Petri, a top infectious disease expert, offers important insights into how to know a COVID-19 vaccine is safe and effective.
Here’s a link to a great article outlining nine reasons for optimism that we’ll have a COVID-19 vaccine by next year.